DK1237549T3 - Lipoxin A4 og dets analoger til behandling af törre öjne - Google Patents
Lipoxin A4 og dets analoger til behandling af törre öjneInfo
- Publication number
- DK1237549T3 DK1237549T3 DK00977069T DK00977069T DK1237549T3 DK 1237549 T3 DK1237549 T3 DK 1237549T3 DK 00977069 T DK00977069 T DK 00977069T DK 00977069 T DK00977069 T DK 00977069T DK 1237549 T3 DK1237549 T3 DK 1237549T3
- Authority
- DK
- Denmark
- Prior art keywords
- lipoxin
- analogues
- treatment
- dry eyes
- eyes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16440699P | 1999-11-09 | 1999-11-09 | |
PCT/US2000/030707 WO2001034144A1 (en) | 1999-11-09 | 2000-11-08 | Lipoxin a4 and its analogs for the treatment of dry eye |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1237549T3 true DK1237549T3 (da) | 2004-06-07 |
Family
ID=22594348
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00977069T DK1237549T3 (da) | 1999-11-09 | 2000-11-08 | Lipoxin A4 og dets analoger til behandling af törre öjne |
Country Status (17)
Country | Link |
---|---|
US (1) | US6645978B1 (zh) |
EP (1) | EP1237549B1 (zh) |
JP (1) | JP2003514782A (zh) |
CN (1) | CN1387435A (zh) |
AT (1) | ATE258791T1 (zh) |
AU (1) | AU1475701A (zh) |
BR (1) | BR0015392A (zh) |
CA (1) | CA2386878A1 (zh) |
DE (1) | DE60008143T2 (zh) |
DK (1) | DK1237549T3 (zh) |
ES (1) | ES2215752T3 (zh) |
HK (1) | HK1046365A1 (zh) |
MX (1) | MXPA02004617A (zh) |
PL (1) | PL356100A1 (zh) |
PT (1) | PT1237549E (zh) |
TR (2) | TR200201244T2 (zh) |
WO (1) | WO2001034144A1 (zh) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8722654B2 (en) * | 2001-03-02 | 2014-05-13 | The Brigham And Women's Hospital, Inc. | Lipoxin analogs as novel inhibitors of angiogenesis |
BR0213179A (pt) * | 2001-10-11 | 2004-09-14 | Alcon Inc | Métodos para tratamento de olhos secos por uma combinação de um esteróide antiinflamatório e um secretagogo de muc-1 |
US6831186B2 (en) | 2001-11-06 | 2004-12-14 | Schering Aktiengesellschft | Lipoxin A4 analogs |
EP1551399A4 (en) * | 2002-09-30 | 2011-01-05 | Mark A Babizhayev | METHOD FOR THE TOPICAL TREATMENT OF EYE DISEASES AND COMPOSITION AND DEVICE FOR THIS TREATMENT |
US9216106B2 (en) * | 2003-04-09 | 2015-12-22 | Directcontact Llc | Device and method for the delivery of drugs for the treatment of posterior segment disease |
US20050208102A1 (en) * | 2003-04-09 | 2005-09-22 | Schultz Clyde L | Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases |
US20050255144A1 (en) * | 2003-04-09 | 2005-11-17 | Directcontact Llc | Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases |
US20050074497A1 (en) * | 2003-04-09 | 2005-04-07 | Schultz Clyde L. | Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases |
US7923471B2 (en) * | 2004-05-14 | 2011-04-12 | Alcon, Inc. | Method of treating dry eye disorders and uveitis |
PT1744736E (pt) * | 2004-05-14 | 2010-01-05 | Alcon Inc | Método de tratamento de distúrbios do olho seco e uveíte |
EP2147686A1 (en) * | 2004-10-01 | 2010-01-27 | Menicon Co., Ltd. | Method for packaging contact lenses |
CN101052387A (zh) * | 2004-11-09 | 2007-10-10 | 爱尔康公司 | 用于治疗眼部疾病以及与过度增生和血管生成反应有关的疾病的5,6,7-三羟基庚酸及类似物 |
US20060134171A1 (en) * | 2004-12-16 | 2006-06-22 | Alcon, Inc. | Agents which regulate, inhibit, or modulate the activity and/or expression of formyl peptide receptors as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies |
US20060154981A1 (en) * | 2005-01-12 | 2006-07-13 | Alcon, Inc. | Method of reducing intraocular pressure and treating glaucoma |
US7687539B1 (en) | 2005-11-07 | 2010-03-30 | Alcon Research, Ltd. | Method of treating ocular allergy |
CL2007003468A1 (es) | 2006-12-04 | 2008-07-04 | Bayer Schering Pharma Ag | Sal de potasio cristalina de analogos de lipoxina a4; metodode sintesis; composicion farmaceutica; y uso en el tratamiento de trastornos inflamatorios o autoinmunes. |
CN103191129A (zh) * | 2007-10-12 | 2013-07-10 | C.T.辨析有限公司 | 治疗眼睛病症的脂氧化物类化合物 |
AU2014201375B2 (en) * | 2007-10-12 | 2015-11-05 | Resolvyx Pharmaceuticals, Inc. | Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds, or oxylipin compounds for the treatment of ophthalmic conditions |
US20100324138A1 (en) * | 2007-10-29 | 2010-12-23 | Bazan Nicolas G | Lipoxin A4 Protection for Retinal Cells |
US8729128B2 (en) * | 2007-10-30 | 2014-05-20 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Lipoxin A4 protection for cornea endothelial cells |
US10383839B2 (en) | 2011-06-30 | 2019-08-20 | Johnson & Johnson Vision Care, Inc. | Esters for treatment of ocular inflammatory conditions |
WO2018067694A1 (en) * | 2016-10-04 | 2018-04-12 | UND Life Sciences, LLC | Composition of bioactive lipids and methods of use thereof |
US11439615B2 (en) * | 2017-03-09 | 2022-09-13 | University Health Network | Lipoxin and lipoxin analogue mediated neuroprotection and treatments |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3991759A (en) | 1975-10-28 | 1976-11-16 | Alza Corporation | Method and therapeutic system for treating aqueous deficient dry eye |
US4131651A (en) | 1977-10-25 | 1978-12-26 | Barnes-Hind Pharmaceuticals, Inc. | Treatment of dry eye |
US4409205A (en) | 1979-03-05 | 1983-10-11 | Cooper Laboratories, Inc. | Ophthalmic solution |
US4370325A (en) | 1979-03-30 | 1983-01-25 | Dermik Laboratories | Pharmaceutical compositions and method of treatment |
US4576758A (en) | 1984-06-01 | 1986-03-18 | The Upjohn Company | Anti-inflammatory lipoxin B analogs |
US4868154A (en) | 1986-02-19 | 1989-09-19 | Eye Research Institute Of Retina Foundation | Stimulation of tear secretion with melanocyte stimulating hormones |
US4753945A (en) | 1986-02-19 | 1988-06-28 | Eye Research Institute Of Retina Foundation | Stimulation of tear secretion with phosphodiesterase inhibitors |
US4883658A (en) | 1986-04-28 | 1989-11-28 | Holly Frank J | Ophthalmic solution for treatment of dry-eye syndrome |
US4744980A (en) | 1986-04-28 | 1988-05-17 | Holly Frank J | Ophthalmic solution for treatment of dry eye syndrome |
US4804539A (en) | 1986-07-28 | 1989-02-14 | Liposome Technology, Inc. | Ophthalmic liposomes |
US4818537A (en) | 1986-10-21 | 1989-04-04 | Liposome Technology, Inc. | Liposome composition for treating dry eye |
US4966773A (en) | 1986-11-25 | 1990-10-30 | Alcon Laboratories, Inc. | Topical ophthalmic compositions containing microfine retinoid particles |
US4914088A (en) | 1987-04-02 | 1990-04-03 | Thomas Glonek | Dry eye treatment solution and method |
US5278151A (en) | 1987-04-02 | 1994-01-11 | Ocular Research Of Boston, Inc. | Dry eye treatment solution |
US5075104A (en) | 1989-03-31 | 1991-12-24 | Alcon Laboratories, Inc. | Ophthalmic carboxy vinyl polymer gel for dry eye syndrome |
US5079261A (en) | 1989-04-28 | 1992-01-07 | Brigham And Women's Hospital | Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
US5174988A (en) | 1989-07-27 | 1992-12-29 | Scientific Development & Research, Inc. | Phospholipid delivery system |
US5041434A (en) | 1991-08-17 | 1991-08-20 | Virginia Lubkin | Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
ZA912797B (en) | 1990-05-29 | 1992-12-30 | Boston Ocular Res | Dry eye treatment process and solution |
ATE132366T1 (de) | 1990-05-29 | 1996-01-15 | Boston Ocular Res | Zusammensetzung zur behandlung von dry eye erkrankungen |
ATE141502T1 (de) | 1991-01-15 | 1996-09-15 | Alcon Lab Inc | Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen |
ZA927277B (en) | 1991-10-02 | 1993-05-19 | Boston Ocular Res | Dry eye treatment process and solution. |
CA2133966C (en) | 1992-04-21 | 1997-09-09 | David A. Sullivan | Ocular androgen therapy in sjogren's syndrome |
US5290572A (en) | 1992-08-06 | 1994-03-01 | Deo Corporation | Opthalmic composition for treating dry eye |
US5455265A (en) | 1993-02-11 | 1995-10-03 | Allergan, Inc. | Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors |
US6048897A (en) * | 1993-06-15 | 2000-04-11 | Brigham And Women's Hospital | Lipoxin compounds and their use in treating cell proliferative disorders |
US5441951A (en) * | 1994-06-15 | 1995-08-15 | Brigham & Women's Hospital | Lipoxin compounds |
JPH08512023A (ja) * | 1993-06-15 | 1996-12-17 | ブリガム・アンド・ウイメンズ・ホスピタル | リポキシン化合物 |
US5696166A (en) * | 1995-10-31 | 1997-12-09 | Yanni; John M. | Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
US5800807A (en) | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
-
2000
- 2000-11-08 AT AT00977069T patent/ATE258791T1/de active
- 2000-11-08 MX MXPA02004617A patent/MXPA02004617A/es unknown
- 2000-11-08 AU AU14757/01A patent/AU1475701A/en not_active Abandoned
- 2000-11-08 DE DE60008143T patent/DE60008143T2/de not_active Expired - Lifetime
- 2000-11-08 PL PL00356100A patent/PL356100A1/xx unknown
- 2000-11-08 TR TR2002/01244T patent/TR200201244T2/xx unknown
- 2000-11-08 EP EP00977069A patent/EP1237549B1/en not_active Expired - Lifetime
- 2000-11-08 ES ES00977069T patent/ES2215752T3/es not_active Expired - Lifetime
- 2000-11-08 BR BR0015392-3A patent/BR0015392A/pt not_active Application Discontinuation
- 2000-11-08 DK DK00977069T patent/DK1237549T3/da active
- 2000-11-08 US US09/787,789 patent/US6645978B1/en not_active Expired - Lifetime
- 2000-11-08 CN CN00815469A patent/CN1387435A/zh active Pending
- 2000-11-08 TR TR2004/00526T patent/TR200400526T4/xx unknown
- 2000-11-08 JP JP2001536142A patent/JP2003514782A/ja not_active Withdrawn
- 2000-11-08 CA CA002386878A patent/CA2386878A1/en not_active Abandoned
- 2000-11-08 WO PCT/US2000/030707 patent/WO2001034144A1/en active IP Right Grant
- 2000-11-08 PT PT00977069T patent/PT1237549E/pt unknown
-
2002
- 2002-10-26 HK HK02107772.7A patent/HK1046365A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA2386878A1 (en) | 2001-05-17 |
CN1387435A (zh) | 2002-12-25 |
HK1046365A1 (zh) | 2003-01-10 |
WO2001034144A1 (en) | 2001-05-17 |
EP1237549B1 (en) | 2004-02-04 |
JP2003514782A (ja) | 2003-04-22 |
DE60008143D1 (de) | 2004-03-11 |
PL356100A1 (en) | 2004-06-14 |
DE60008143T2 (de) | 2004-12-30 |
ES2215752T3 (es) | 2004-10-16 |
TR200201244T2 (tr) | 2002-08-21 |
US6645978B1 (en) | 2003-11-11 |
PT1237549E (pt) | 2004-06-30 |
EP1237549A1 (en) | 2002-09-11 |
BR0015392A (pt) | 2002-06-25 |
AU1475701A (en) | 2001-06-06 |
MXPA02004617A (es) | 2004-09-10 |
ATE258791T1 (de) | 2004-02-15 |
TR200400526T4 (tr) | 2004-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1237549T3 (da) | Lipoxin A4 og dets analoger til behandling af törre öjne | |
DE60019473D1 (de) | (S,S)-Reboxetin zur Behandlung von peripheren Neuropathien | |
EA200501095A1 (ru) | Фенилацетамиды и их применение в качестве модуляторов глюкокиназы | |
NO20003233L (no) | 4-hydroksykinolin-3-karboksamider og hydrazider som antivirale midler | |
BR0314603A (pt) | Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos | |
DK0760848T3 (da) | Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf | |
ID26033A (id) | Metode penstabilan komposisi bahan farmasi dengan penggunaan khusus dari antioksidan | |
MY129189A (en) | Prostaglandin agonists and their use to treat bone disorders | |
DE60235083D1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
NO941462L (no) | Metoder og sammensetninger for profylaktisk og/eller terapeutisk behandling av organhypofunksjon | |
DK1039912T3 (da) | Angiostatiske midler og præparater til behandling af GLC1A-glaukom | |
BR0307833A (pt) | Sìntese controlada de ziprasidona e suas composições | |
UY26130A1 (es) | Compuestos para tratar la obesidad | |
NO20050664L (no) | 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer | |
CY1117666T1 (el) | 4-((ΦΑΙΝΟΞΥΑΛΚΥΛΟ)ΘΕΙΟ)-ΦΑΙΝΟΞΥΟΞΙΚΑ ΟΞΕΑ ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ PPARδ ΔΙΑΜΕΣΟΛΑΒΟΥΜΕΝΩΝ ΠΑΘΗΣΕΩΝ | |
CY1107531T1 (el) | Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου | |
CL2004000551A1 (es) | Compuestos derivados de triazol sustituidos con biarilo, sus sales, bloqueadores del canal de sodio; procedimiento de preparacion; composicion farmaceutica; y su uso en el tratamiento o prevencion del dolor. | |
BR9708114A (pt) | Análogos xantona para o tratamento de doenças infecciosas. | |
DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
BR0015416A (pt) | Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos | |
ATE273690T1 (de) | Zusammensetzung zur hautdesinfizierung | |
MY147518A (en) | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs | |
NO20025405D0 (no) | Modulatorer for TNF-alfa-signalisering | |
AR020563A1 (es) | Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion | |
DK1383742T3 (da) | Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater |